🔎 Trials Near Me

Home › Hereditary Sensory and Autonomic Neuropathies › Massachusetts › Boston

Hereditary Sensory and Autonomic Neuropathies clinical trials in Boston, MA

6 studies for Hereditary Sensory and Autonomic Neuropathies are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Study of ACR-2316 in Specific Advanced Solid Tumors

RecruitingPhase 1/2
  • Beth Israel Deaconess Medical Center, Boston
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT06667141

Online Study of People Who Have Genetic Changes and Features of Autism: Simons Searchlight

RecruitingObservational study
  • Boston Children's Hospital, Boston
All ages · All sexes · Updated Jul 23, 2026 · NCT01238250

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

RecruitingPhase 1/2
  • Massachusetts General Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Ages 18 and older · All sexes · Updated Jul 7, 2026 · NCT05768139

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

RecruitingPhase 1/2
  • Beth Israel Deaconess Medical Center, Boston
  • Dana-Farber Cancer Institute, Boston
Ages 18 and older · All sexes · Updated Jun 23, 2026 · NCT06993844

A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer

RecruitingPhase 1
  • Beth Israel Deaconess Medical Center, Boston
  • Dana-Farber Cancer Institute, Boston
Ages 18 and older · Women · Updated Apr 22, 2026 · NCT05683418

The Cancer of the Pancreas Screening-5 CAPS5)Study

RecruitingPhase 3
  • Dana Farber Cancer Center, Harvard University, Boston
Ages 18 and older · All sexes · Updated Oct 9, 2025 · NCT02000089

Hereditary Sensory and Autonomic Neuropathies trials in other cities

Other studies in Boston

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.